Cancer immunotherapy was highlighted in the Seattle Business Magazine’s December issue. Nexgenia was featured as a company with tools to help the manufacturing process of cell-based cancer immunotherapies. Read the full article here.
E: adm@nexgeniacorp.com | T: 206.812.1529
